Not sure you can follow charts with this stock. Really it’s all about news and nothing else. Without it we are probably done , but there is still a very strong chance we hear something in the coming months. Obviously no revenue and lots of debt. But once again they did produce Mipsigargin and it still has the potential to be developed into a cancer drug . Maybe deals in the making as a few bios try it in combination testing . This drug ran out of money , but the potential never died. It makes little sense to discontinue its development. It is not a failed drug as there have been zero negative reports on it
News 
Market Data 
Discover 
